Publications

"Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia.

Kielmann, K; Vidal, N; Riekstina, V; Krutikov, M; Van der Werf, MJ; Biraua, E; Duric, P; MOORE, DA J;

2018

PloS one, (2018).13 10 10.1371/journal.pone.0203937.

Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.

KAMPMANN, B; Seddon, JA; Paton, J; Nademi, Z; Keane, D; Williams, B; Williams, A; Liebeschutz, S; Riddell, A; Bernatoniene, J; Patel, S; Martinez, N; McMaster, P; Basu-Roy, R; Welch, SB;

2018

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (2018).197 8 10.1164/rccm.201707-1487OC.

Cost of point-of-care lateral flow urine lipoarabinomannan antigen testing in HIV-positive adults in South Africa.

Mukora, R; Tlali, M; Monkwe, S; Charalambous, S; KARAT, AS; FIELDING, KL; GRANT, AD; VASSALL, A;

2018

The international journal of tuberculosis and lung disease, (2018).22 9 10.5588/ijtld.18.0046.

Methylation in Mycobacterium tuberculosis is lineage specific with associated mutations present globally.

PHELAN, J; De Sessions, PF; TIENTCHEU, L; Perdigao, J; Machado, D; Hasan, R; Hasan, Z; Bergval, IL; Anthony, R; MCNERNEY, R; ANTONIO, M; Portugal, I; Viveiros, M; CAMPINO, S; HIBBERD, ML; CLARK, TG;

2018

Scientific reports, (2018).8 1 10.1038/s41598-017-18188-y.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project,; Allix-Béguec, C; Arandjelovic, I; Bi, L; Beckert, P; Bonnet, M; Bradley, P; Cabibbe, AM; Cancino-Muñoz, I; Caulfield, MJ; Chaiprasert, A; Cirillo, DM; Clifton, DA; Comas, I; Crook, DW; De Filippo, MR; De Neeling, H; Diel, R; Drobniewski, FA; Faksri, K; Farhat, MR; Fleming, J; Fowler, P; Fowler, TA; Gao, Q; ... Zhu, B.

2018

New England Journal of Medicine, (2018).379 15 10.1056/NEJMoa1800474.

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts.

Duffy, FJ; Thompson, E; Downing, K; Suliman, S; Mayanja-Kizza, H; Boom, WH; Thiel, B; Weiner Iii, J; Kaufmann, SH E; Dover, D; Tabb, DL; DOCKRELL, HM; Ottenhoff, TH M; Tromp, G; Scriba, TJ; Zak, DE; Walzl, G; GC6-74 Consortium,;

2018

Frontiers in immunology, (2018).9 APR 10.3389/fimmu.2018.00661.

Should NICE reconsider the 2016 UK guidelines on TB contact tracing? A cost-effectiveness analysis of contact investigations in London.

CAVANY, SM; VYNNYCKY, E; Anderson, CS; Maguire, H; SANDMANN, F; Thomas, HL; WHITE, RG; SUMNER, T;

2018

Thorax, (2018).74 2 10.1136/thoraxjnl-2018-211662.

Programmatic management of patients with pre-extensively drug-resistant tuberculosis in Peru, 2011-2014.

Alarcón, V; Alarcón-Arrascue, E; Mendoza-Ticona, A; Obregón, G; Cornejo, J; Vargas, D; De Los Ríos, J; MOORE, DA J; Heldal, E;

2018

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, (2018).22 10 10.5588/ijtld.17.0900.

Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study.

Chang, ST; Chihota, VN; FIELDING, KL; GRANT, AD; HOUBEN, RM; WHITE, RG; CHURCHYARD, GJ; Eckhoff, PA; Wagner, BG;

2018

BMC medicine, (2018).16 1 10.1186/s12916-018-1037-3.

Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South Africa.

BOZZANI, FM; Mudzengi, D; SUMNER, T; Gomez, GB; Hippner, P; Cardenas, V; Charalambous, S; WHITE, R; VASSALL, A;

2018

Cost effectiveness and resource allocation, (2018).16 1 10.1186/s12962-018-0113-z.